Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Improving Patient Understanding of Their Prostate Cancer Diagnosis Using AI

NCT: NCT07040501 · NOT_YET_RECRUITING

NCT IDNCT07040501
StatusNOT_YET_RECRUITING
Start Date2026-06
Completion2027-01

Brief Summary

The purpose of this study is to determine if ChatGPT (an artificial intelligence driven chatbot) can help patients better understand their own pathology results and prostate cancer diagnosis.

Frequently Asked Questions

What is Improving Patient Understanding of Their Prostate Cancer Diagnosis Using AI?

Improving Patient Understanding of Their Prostate Cancer Diagnosis Using AI is a clinical trial registered under NCT07040501. Current status: NOT_YET_RECRUITING.

What is the status of NCT07040501?

The current status of NCT07040501 (Improving Patient Understanding of Their Prostate Cancer Diagnosis Using AI) is: NOT_YET_RECRUITING.

When did Improving Patient Understanding of Their Prostate Cancer Diagnosis Using AI start?

Improving Patient Understanding of Their Prostate Cancer Diagnosis Using AI started on 2026-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑